Company: ACBM
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001640334-25-001999
Chunk: 34

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 8
Chunk 34
---
 $2,250 and $0 and paid expenses of $56,457 and $6,110 on behalf of the Company, respectively. At September 30, 2025 and December 31, 2024, the Company owed $299,260 and $124,488 to the minority stockholder referred to in the preceding paragraph for non-interest-bearing advances made to or expenses paid on behalf of the Company, and these amounts are due on demand.

 9Table of Contents

At September 30, 2025 and December 31, 2024, the Company owed $1,100 to its former chief executive officer who resigned in August 2025 for non-interest-bearing advances made to or paid expenses on behalf of the Company which amounts are due on demand. The Company has imputed interest at the rate of 4% on the advances made to or paid expenses on behalf of the Company in the amount of $6,025 and $3,134 during the nine months ended September 30, 2025 and 2024, respectively, and in the amount of $2,710 and $1,123 during the three months ended September 30, 2025 and 2024, respectively.

NOTE 5 - LEASES On November 1, 2023, the Company entered into a lease agreement to rent a storage facility in Hong Kong for a two-year term at an annual rental of HK$17,900 (approximately $2,315) per month and HK$35,800 (approximately $4,600) as a security deposit.  These payments were paid by a minority stockholder on behalf of the Company (see Note 4).  The lease expires in December 2025. On August 30, 2025, the Company terminated the lease agreement. The Company paid the August rent expense by applying security deposit and received the remaining security deposit of $2,285.  The Company recognized total lease expenses of $18,520 and $20,835 for the nine months ended September 30, 2025 and 2024, respectively and $4,630 and $6,945 for the three months ended September 30, 2025 and 2024, respectively.

NOTE 6 - SUBSEQUENT EVENTS The Company has evaluated subsequent events that have occurred after the date of the balance sheet through the date of the issuance of these unaud